Geneos Wealth Management’s Insmed INSM Stock Holding History

Geneos Wealth Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$44.1K	Hold	414	–	–	﹤0.01%	1509
2026 Q1	$67.7K	Hold	414	–	–	﹤0.01%	1310
2025 Q4	$72.1K	Buy	414 +341	+467%	+$62.2K	﹤0.01%	1266
2025 Q3	$10.5K	Sell	73 -38	-34%	-$4.66K	﹤0.01%	1947
2025 Q2	$11.2K	Buy	111 +57	+106%	+$4.36K	﹤0.01%	2277
2025 Q1	$4.12K	Hold	54	–	–	﹤0.01%	2582
2024 Q4	$3.73K	Buy	+54	New	+$3.89K	﹤0.01%	2434
2022 Q1	–	Sell	-272	Closed	-$7K	–	2865
2021 Q4	$7K	Hold	272	–	–	﹤0.01%	2301
2021 Q3	$7K	Hold	272	–	–	﹤0.01%	2350
2021 Q2	$7K	Hold	272	–	–	﹤0.01%	2335
2021 Q1	$9K	Hold	272	–	–	﹤0.01%	2420
2020 Q4	$9K	Hold	272	–	–	﹤0.01%	2255
2020 Q3	$9K	Hold	272	–	–	﹤0.01%	1983
2020 Q2	$7K	Buy	+272	New	+$6.45K	﹤0.01%	2045

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Geneos Wealth Management's INSM Position: Q2 2026 in Review

Geneos Wealth Management held its Insmed (INSM) position steady in Q2 2026 at 414 shares worth $44.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1509.

Geneos Wealth Management first reported a position in INSM in Q2 2020 and has held it in 14 quarters since. The position peaked at $72.1K in Q4 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Geneos Wealth Management held 414 shares of Insmed worth $44.1K as of Q2 2026.
Geneos Wealth Management left its Insmed share count unchanged in Q2 2026.
Insmed made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1509 holding.
Geneos Wealth Management first reported a position in Insmed in Q2 2020 and has held it in 14 quarters since.
Geneos Wealth Management's Insmed position peaked at $72.1K in Q4 2025.
667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.